Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Statistics in Medicine|September 13, 2007
Optimal phase I dose-escalation trial designs in oncology--a simulation studyOke Gerke, Harald SiedentopAJR. American Journal of Roentgenology|May 20, 2004
Computer-assisted quantitative analysis of bone marrow edema of the knee: initial experience with a new methodMarius E Mayerhoefer, Martin Breitenseher, Siegfried Hofmann, et al.American Journal of Therapeutics|December 31, 2010
Differentiation of arginine vasopressin antagonistic effects by selective V2 versus dual V2/V1a receptor blockade in a preclinical heart failure modelThomas Mondritzki, Peter Kolkhof, Hani N Sabbah, et al.Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|July 11, 2008
MRI-demonstrated outcome of subchondral stress fractures of the knee after treatment with iloprost or tramadol: observations in 14 patientsMarius E Mayerhoefer, Josef Kramer, Martin J Breitenseher, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 27, 2016
Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathyHeinz-Peter Schultheiss, Cornelia Piper, Olaf Sowade, et al.American Heart Journal|April 28, 2023
Electronic health record characterization and outcomes of heart failure with preserved ejection fractionVishal N Rao, Derek D Cyr, Lisa M Wruck, et al.The Lancet. Neurology|May 14, 2011
Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trialRobert E Gross, Raymond L Watts, Robert A Hauser, et al.The New England Journal of Medicine|August 2, 2002
Inhaled iloprost for severe pulmonary hypertensionHorst Olschewski, Gerald Simonneau, Nazzareno Galiè, et al.Therapeutic Innovation & Regulatory Science|June 10, 2020
Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank MeetingTrevor A Lentz, Lesley H Curtis, Frank W Rockhold, et al.Pageof 1